I am focused on supporting client innovation through the protection of their intellectual property.
Dr. Kimberlee “Kim” Hixon leverages her previous experience in biochemistry, immunology and cancer biology to impact patent prosecution in the life science industry.
Kim earned her Ph.D. in biological and biomedical sciences from Harvard University. Her dissertation focused on the regulation of chromatin remodeling in immune cell development and hematologic cancers.
Harvard University, Ph.D., Biological and Biomedical Sciences, 2025
Simmons University, B.Sc., Biochemistry and Sociology, 2017
Experience
Provided IP diligence support to Genmab A/S (NASDAQ: GMAB), an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases, in its acquisition of Merus for $8B, expanding Genmab’s late-stage pipeline
Business Development Fellow, Harvard University
Mini-MBA Harvard GSAS Business Club, Harvard University
Publications
Battistello, Hixon, and Comstock et al., “Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion.” Molecular cell vol. 83,8 (2023): 1216-1236.e12. doi:10.1016/j.molcel.2023.02.026
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
